Skye Bioscience Inc
NASDAQ:SKYE

Watchlist Manager
Skye Bioscience Inc Logo
Skye Bioscience Inc
NASDAQ:SKYE
Watchlist
Price: 4.17 USD -2.57%
Market Cap: 126.5m USD
Have any thoughts about
Skye Bioscience Inc?
Write Note

Wall Street
Price Targets

SKYE Price Targets Summary
Skye Bioscience Inc

Wall Street analysts forecast SKYE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SKYE is 18.36 USD with a low forecast of 14.14 USD and a high forecast of 22.05 USD.

Lowest
Price Target
14.14 USD
239% Upside
Average
Price Target
18.36 USD
340% Upside
Highest
Price Target
22.05 USD
429% Upside

SKYE Last Price Targets
Skye Bioscience Inc

The latest public price target was made on Sep 10, 2024 by Jonathan Wolleben from JMP Securities , who expects SKYE stock to rise by 260% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Jonathan Wolleben
JMP Securities
15 USD
Upside 260%
2 months ago
Sep 10, 2024
Skye Bioscience initiated with an Outperform at JMP Securities
TheFly
Albert Lowe
Craig-Hallum
18 USD
Upside 332%
2 months ago
Aug 26, 2024
Craig-Hallum Reiterates Buy Rating on Skye Bioscience (SKYE)
StreetInsider
Jay Olson
Oppenheimer
21 USD
Upside 404%
5 months ago
Jun 10, 2024
Skye Bioscience (SKYE) PT Lowered to $21 at Oppenheimer
StreetInsider
Kristen Kluska
Cantor Fitzgerald
21 USD
Upside 404%
5 months ago
May 23, 2024
Skye Bioscience initiated with an Overweight at Cantor Fitzgerald
TheFly
Jay Olson
Oppenheimer
25 USD
Upside 500%
7 months ago
Apr 11, 2024
Oppenheimer Starts Skye Bioscience (SYKE) at Outperform Following Uplisting to Nasdaq (correction)
StreetInsider
Edward Tenthoff
Piper Sandler
20 USD
Upside 380%
8 months ago
Mar 14, 2024
Skye Bioscience (SKYE) PT Raised to $20 at Piper Sandler
StreetInsider
Show More Price Targets
Show Less Price Targets
Jonathan Wolleben
JMP Securities
Price Target 15 USD
Upside/Downside 260%
View Source
Albert Lowe
Craig-Hallum
Price Target 18 USD
Upside/Downside 332%
View Source
Jay Olson
Oppenheimer
Price Target 21 USD
Upside/Downside 404%
View Source
Kristen Kluska
Cantor Fitzgerald
Price Target 21 USD
Upside/Downside 404%
View Source
Jay Olson
Oppenheimer
Price Target 25 USD
Upside/Downside 500%
View Source
Edward Tenthoff
Piper Sandler
Price Target 20 USD
Upside/Downside 380%
View Source
Show More Price Targets
Show Less Price Targets
Skye Bioscience Inc Competitors:
Price Targets
ELDN
Eledon Pharmaceuticals Inc
209% Upside
NTLA
Intellia Therapeutics Inc
322% Upside
ALLK
Allakos Inc
224% Upside
CUV
Clinuvel Pharmaceuticals Ltd
107% Upside
FLUO
Fluoguide AS
307% Upside
ALEC
Alector Inc
246% Upside

Revenue
Forecast

Revenue Estimate
Skye Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Skye Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Skye Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SKYE's stock price target?
Price Target
18.36 USD

According to Wall Street analysts, the average 1-year price target for SKYE is 18.36 USD with a low forecast of 14.14 USD and a high forecast of 22.05 USD.

Back to Top